Dose titration should follow FDA-approved guidelines, with increases of 2.5 mg occurring at minimum four-week intervals to minimize gastrointestinal adverse effects such as nausea, vomiting, and diarrhea
Diabetes 2025;74
Information and data from the secondary sources have been obtained from various printable and nonprintable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases
1 session every 2 weeks
Dulaglutide, albiglutide, liraglutide, and semaglutide are human GLP-1 backbone agents
Book Your Consultation Call or text us to schedule your consultation.